MX1 Shares Micro-X Limited
ASX · ASXLast in our picks 2026-10-26 — not in the current list; analysis below is from that screen
Portable medical imaging growth and sharp recent momentum create high-upside commercial optionality.
Future value: $0.06 (+46.34%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Recent trading data showed Micro-X as a leading percentage gainer.
- ▸Above 50-day MA (+7.58%)
- ▸~46% upside to price target
Is MX1 a buy right now?
Trend: MX1 is trading above the 50-day average (+2.50%), RSI 25 — oversold territory, with a 3-month return of +51.85%.
Valuation & quality: Micro-X Limited trades on forward P/E -10.3, price-to-book 5.86; fundamentals show net margin -65.5%, return on equity -158.0%, revenue growth -32.0% year on year.
Analyst consensus: 1 analysts have a mean 12-month price target of A$0.06 (+46.3% vs the last close; range A$0.06 – A$0.06), consensus rating “none”.
Our screen: BUY (score 2) — Portable medical imaging growth and sharp recent momentum create high-upside commercial optionality.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -37.50% | +0.00% | -20.00% | +0.00% | -25.00% | +0.00% | +100.00% | -33.30% |
Fundamentals
Analyst price target
Technical signals
About Micro-X Limited
Micro-X Limited engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa.
Sector: Healthcare · Industry: Medical Devices · Australia · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.